SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-102610
Filing Date
2016-05-16
Accepted
2016-05-16 16:15:40
Documents
32
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v439162_10q.htm 10-Q 236447
2 EXHIBIT 31.1 v439162_ex31-1.htm EX-31.1 10164
3 EXHIBIT 31.2 v439162_ex31-2.htm EX-31.2 10121
4 EXHIBIT 32.1 v439162_ex32-1.htm EX-32.1 4109
5 EXHIBIT 32.2 v439162_ex32-2.htm EX-32.2 4081
  Complete submission text file 0001144204-16-102610.txt   1383318

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT accp-20160331.xml EX-101.INS 170895
7 XBRL TAXONOMY EXTENSION SCHEMA accp-20160331.xsd EX-101.SCH 13116
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20160331_cal.xml EX-101.CAL 34549
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20160331_def.xml EX-101.DEF 55487
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20160331_lab.xml EX-101.LAB 206205
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20160331_pre.xml EX-101.PRE 125617
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 161653993
SIC: 2834 Pharmaceutical Preparations